ArticleBMC global and public health2025
Tuberculosis treatment outcomes after transfer or release from incarceration: a retrospective cohort study from Brazil.
Article in BMC global and public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tuberculosis in prisons: an integrated prevention and care cascade for a persistent structural epidemic.Frontiers in public health · 2026Review
Corrections and comments
- Update of
Authors and funding
10 authors.
Funding
Abstract
backgroundTuberculosis (TB) disproportionately affects people deprived of liberty (PDL). Prior studies have shown higher TB treatment completion rates among PDL compared to the general population. However, little is known about how incarceration-related movements such as transfers between facilities and releases to the community affect TB treatment outcomes.
methodsWe linked person-level incarceration data with TB notifications data from the Notifiable Disease Information System for the Brazilian state of Mato Grosso do Sul between January 2006 and December 2018. We constructed a cohort of PDL who were newly diagnosed with drug-susceptible TB and initiated treatment. We compared treatment outcomes between individuals who remained in the same carceral facility and those who were transferred to other facilities or released from incarceration during treatment. We computed the covariate-adjusted relative risk of unfavorable treatment outcomes for individuals transferred or released during treatment.
resultsWe identified 1261 PDL who initiated TB treatment. Of these individuals, 842 (66.8%) remained in the same carceral facility, 256 (20.3%) were transferred to other facilities, and 163 (12.9%) were released to the community during treatment. Among those who remained in the same carceral facility, 72.9% (614/842) were successfully treated within 8 months following treatment initiation. In contrast, only 61.7% (158/256) of those who were transferred and 50.3% (82/163) of those who were released achieved TB treatment success within 8 months. After adjusting for covariates, the risk of unfavorable treatment outcomes was 1.4 (95% CI: 1.2 to 1.7) times as high for individuals transferred to other facilities and 1.6 (95% CI: 1.3 to 2.0) times as high for individuals released from incarceration, compared to those who remained in the same facility during treatment. For individuals released less than 2 months into treatment, the risk of unfavorable treatment outcomes was twice as high (adjusted relative risk [aRR]: 2.1, 95% CI: 1.6-2.7).
conclusionsTransfers between facilities and releases from incarceration are common and may pose barriers to TB treatment completion. Strategies for ensuring continuity of care across carceral facilities and between prison and community health systems are urgently needed to improve TB outcomes for individuals impacted by incarceration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.